Steven D. Nathan - 11 Mar 2024 Form 4 Insider Report for Gossamer Bio, Inc. (GOSS)

Role
Director
Signature
/s/ Jeff Boerneke, Attorney-in-Fact
Issuer symbol
GOSS
Transactions as of
11 Mar 2024
Net transactions value
$0
Form type
4
Filing time
12 Mar 2024, 19:50:55 UTC
Next filing
26 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GOSS Stock Option (Right to Buy) Award $0 +230,000 $0.000000 230,000 11 Mar 2024 Common Stock 230,000 $1.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the total number of shares subject to the option vest on the last day of each one-month period thereafter, subject to the Reporting Person's continuous service to the Corporation on each such vesting date.